[Chronic hepatitis C in patients coinfected by human immunodeficiency virus].
Sánchez-Quijano
A
A
Grupo Estudio Hepatitis Vírica y SIDA, Hospital Universitario Virgen del Rocío, Sevilla, Spain. aquijano@cica.es
Leal
M
M
Lissen
E
E
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D004359:Drug Therapy, Combination; D005260:Female; D005544:Forecasting; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D019562:Viral Load
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons
Hepatitis crónica por virus C en pacientes coinfectados por el virus de la inmunodeficiencia humana.